Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 714

1.

Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time.

Benedetti JK, Zeh J, Corey L.

Ann Intern Med. 1999 Jul 6;131(1):14-20.

PMID:
10391810
[PubMed - indexed for MEDLINE]
2.

Recurrence rates in genital herpes after symptomatic first-episode infection.

Benedetti J, Corey L, Ashley R.

Ann Intern Med. 1994 Dec 1;121(11):847-54.

PMID:
7978697
[PubMed - indexed for MEDLINE]
3.

Natural history of genital herpes simplex virus type 1 infection.

Engelberg R, Carrell D, Krantz E, Corey L, Wald A.

Sex Transm Dis. 2003 Feb;30(2):174-7.

PMID:
12567178
[PubMed - indexed for MEDLINE]
4.

An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.

Fife KH, Warren TJ, Justus SE, Heitman CK; HS2100275 STUDY TEAM.

Sex Transm Dis. 2008 Jul;35(7):668-73. doi: 10.1097/OLQ.0b013e31816d1f42.

PMID:
18461016
[PubMed - indexed for MEDLINE]
5.

Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.

Handsfield HH, Warren T, Werner M, Phillips JA.

Sex Transm Dis. 2007 Jun;34(6):339-43.

PMID:
17065847
[PubMed - indexed for MEDLINE]
6.

Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region.

Sucato G, Wald A, Wakabayashi E, Vieira J, Corey L.

J Infect Dis. 1998 Apr;177(4):1069-72.

PMID:
9534984
[PubMed - indexed for MEDLINE]
Free Article
7.

Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.

Kim HN, Wald A, Harris J, Almekinder J, Heitman C, Corey L.

Sex Transm Dis. 2008 Feb;35(2):124-8.

PMID:
17921912
[PubMed - indexed for MEDLINE]
8.

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L.

N Engl J Med. 2000 Mar 23;342(12):844-50.

PMID:
10727588
[PubMed - indexed for MEDLINE]
Free Article
9.

Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.

Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr.

Infect Dis Obstet Gynecol. 2001;9(2):75-80.

PMID:
11495557
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Reducing the risk of transmitting genital herpes: advances in understanding and therapy.

Leone P.

Curr Med Res Opin. 2005 Oct;21(10):1577-82. Review.

PMID:
16238897
[PubMed - indexed for MEDLINE]
11.

Virologic characteristics of subclinical and symptomatic genital herpes infections.

Wald A, Zeh J, Selke S, Ashley RL, Corey L.

N Engl J Med. 1995 Sep 21;333(12):770-5.

PMID:
7643884
[PubMed - indexed for MEDLINE]
Free Article
12.

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, Stratchounsky LS, Mertz G, Keene ON, Watson HA, Tait D, Vargas-Cortes M; Valacyclovir HSV Transmission Study Group.

N Engl J Med. 2004 Jan 1;350(1):11-20.

PMID:
14702423
[PubMed - indexed for MEDLINE]
Free Article
13.

Prevention of perinatal herpes: prophylactic antiviral therapy?

Scott LL.

Clin Obstet Gynecol. 1999 Mar;42(1):134-48; quiz 174-5. Review.

PMID:
10073307
[PubMed - indexed for MEDLINE]
14.

Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL.

JAMA. 1998 Sep 9;280(10):887-92.

PMID:
9739972
[PubMed - indexed for MEDLINE]
15.

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.

Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, Jacobs R, Van Dyke R, Burchett S, Soong SJ, Lakeman A, Whitley R.

Pediatr Infect Dis J. 1996 Mar;15(3):247-54.

PMID:
8852914
[PubMed - indexed for MEDLINE]
16.

Genital herpes in a sexually-transmitted infection clinic in Singapore: a 1-year retrospective study.

Theng TS, Chan RK.

Ann Acad Med Singapore. 2004 Mar;33(2):200-3.

PMID:
15098634
[PubMed - indexed for MEDLINE]
Free Article
17.

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Wald A, Zeh J, Barnum G, Davis LG, Corey L.

Ann Intern Med. 1996 Jan 1;124(1 Pt 1):8-15.

PMID:
7503497
[PubMed - indexed for MEDLINE]
18.

Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.

Tyring SK, Diaz-Mitoma F, Shafran SD, Locke LA, Sacks SL, Young CL.

J Cutan Med Surg. 2003 Nov-Dec;7(6):449-54.

PMID:
15931690
[PubMed - indexed for MEDLINE]
19.

Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.

Patel R, Bodsworth NJ, Woolley P, Peters B, Vejlsgaard G, Saari S, Gibb A, Robinson J.

Genitourin Med. 1997 Apr;73(2):105-9.

PMID:
9215091
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.

Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A.

Sex Transm Dis. 2008 Apr;35(4):383-6. doi: 10.1097/OLQ.0b013e31815e4190.

PMID:
18362859
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk